Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19.
Weiss LJ, Drayss M, Manukjan G, Zeitlhöfler M, Kleiss J, Weigel M, Herrmann J, Mott K, Beck S, Burkard P, Lâm TT, Althaus K, Bakchoul T, Frantz S, Meybohm P, Nieswandt B, Weismann D, Schulze H.
Weiss LJ, et al. Among authors: kleiss j.
Blood Adv. 2023 Jun 13;7(11):2324-2338. doi: 10.1182/bloodadvances.2022008666.
Blood Adv. 2023.
PMID: 36053793
Free PMC article.